Background: Endocrine disorders have been noted to be on the increase in the developing world, but little is known about their outcomes on the African continent.
Introduction
For several decades, communicable diseases have dominated as the leading cause of morbidity and mortality in low-and middleincome countries (LMICs), especially those in sub-Saharan Africa (SSA). [1] [2] [3] [4] Although infectious diseases account for approximately 69% of deaths in SSA, non-communicable diseases (NCDs) have emerged as a significant cause of death. [5] [6] [7] Endocrine disorders contribute significantly to the NCD burden worldwide, with diabetes leading the way in severity and prevalence. Diabetes accounts for >8% of the global disease burden and 60-70% of the mortality burden. 8 In Ghana, where middle-income status was recently achieved, the menace posed by various endocrine diseases and other NCDs looms large. [9] [10] [11] Recently a review of diabetes cases in the middle belt of Ghana showed a 633% increase in admissions over 31 years. 12 Significant increases in thyroid and other endocrine disorders have been reported in the two main urban areas in Ghana. 13, 14 Despite projected increases in admissions and death rates from NCDs, little attention is paid to them in terms of resource and infrastructure allocation, with most of the weak and limited health care budget in resource-limited countries like Ghana still prioritised towards the treatment of infections and nutritional disorders. The care of NCDs is suboptimal and fractured, leaving the population at significant risk of morbidity and mortality.
Enumerated data on the burden, spectrum and determinants of outcomes of endocrine admissions in less developed countries like Ghana are needed to shed light on the problem and enable policy directives to be initiated to combat NCDs. This study aims to present the spectrum, demography, crude mortality rates and determinants of outcomes of adult endocrine disorders in a tertiary referral hospital in the middle belt of Ghana. situated in Kumasi, in the middle belt of Ghana. The hospital is a 1200-bed hospital accessible to >10 million people, including those from neighbouring countries. The medical unit has 200 hospital beds and offers emergency services, inpatient services and outpatient specialists, as well as general care. The medical records of patients with endocrine disorders admitted to the medical wards over a 9-y period (1 January 2007 -31 December 2015 were retrieved from the hospital admissions and discharge registers. Data collected for the analyses included age, gender, endocrine diagnosis based on International Classification of Disease revision 10 (ICD-10) codes, documented comorbidities, duration of admission and vital status at discharge. The time to discharge or death was calculated by subtracting the date of admission from the date of discharge or death. Endocrine diagnoses were made clinically with the aid of laboratory investigations and in some cases radiological confirmation. For the period under study, five general medical teams admitted all emergency cases. These patients were managed until the general team found the need for subspecialist consultation, in which case the patients were referred to one of the three endocrinologists for further care. Laboratory tests available on site to facilitate clinical diagnosis included full blood count, serum biochemistry for lipid profile, fasting blood sugar, liver and renal function tests, cortisol levels, thyroid function tests, serum calcium, parathyroid hormone and serological tests for human immunodeficiency virus (HIV) and tuberculosis (TB). Radiological investigations available included X-rays, ultrasonography, computed tomography and magnetic resonance imaging. Endocrine disorders were categorised under these main headings: thyroid gland disorders, diabetes mellitus and related disorders, parathyroid gland and related disorders, disorders of the pituitary gland, disorders of the adrenal gland and miscellaneous endocrine diseases. The ICD-10 was used to classify the diseases. Records with incomplete data were excluded from the study. Data were entered into Excel (Microsoft, Redmond, WA, USA) spreadsheets by data entry clerks.
Data analysis
Means and medians were compared using the Student t-test or Mann-Whitney U-test for paired comparisons and analysis of variance or Kruskal-Wallis test for more than two group comparisons, depending on whether continuous variables were parametric or non-parametric. Crude case fatality rates of specific endocrine disorders were calculated by dividing the number of deaths by the number of admissions of the specific endocrine disorders. Predictors of inpatient endocrine mortality were evaluated using Kaplan-Meier survival curves and multivariate Cox proportional hazard regression models. Variables included in the model were the age of admission in years, gender, year of admission and type of endocrine disorder. In bivariate analyses, a p-value of 0.10 was set for selection of variables into the final multivariable model, with visual inspection for compliance with the collinearity assumption. A two-sided p-value <0.05 was considered significant in all statistical analysis, with no adjustments made for multiple comparisons.
Results

Demographic characteristics of endocrine admissions
There were 6265 endocrine admissions between 2007 and 2015. This represented 9.7% of all adult medical admissions (year-to-year range 8.5-11.6%) ( Table 1 ). There was a preponderance of female admissions, with a female:male ratio of 2:1. The median age of admission was 61 y (interquartile range [IQR] 49-72). The median age of admission for males was 61 y (IQR 49-72) and for females was 60 y (IQR 49-71); the difference was not statistically significant (p<0.16). The overall mean age at admission was 52.0±16.1 y. Table 2 shows the spectrum of endocrine disorders and their case fatality rates. The leading endocrine causes of admission were diabetes and its related disorders (86.0%), thyroid disorders (7.7%), miscellaneous disorders of the endocrine glands (1.4%), adrenal disorders (1.3%) and metabolic syndrome (1.1%). 
Spectrum of endocrine disorders
Diabetes-related admissions and mortality
Glycaemic complications Table 3 shows the various diabetes mellitus-related medical admissions. Almost a third of the patients were newly diagnosed with diabetes mellitus. Nine in ten of the admissions were type 2 diabetes. There was a significant difference in the age at presentation of the various types of diabetes, with those with type 2 relatively older compared with type 1 and the other causes of diabetes. The overall crude mortality rate for glycaemic admissions was highest among those with hyperosmolar hyperglycaemic state, hypoglycaemia and diabetic ketoacidosis (DKA), in that order.
Microvascular complications
A total of 1927 (35.4%) of the all diabetes-related admissions were associated with microvascular complications and 988 (18.1%) had nephropathy. The median age of admission of patients with nephropathy was 60 y (IQR 50-71), the male: female ratio was 1.3:1.0 and the mortality associated with nephropathy was 27.6%.
Macrovascular complications
A total of 1035 (22.1%) patients with diabetes admissions presented with a macrovascular complication of diabetes: 492 (9.0 %) had cerebrovascular accidents (CVAs), 261 (5.6%) had coronary artery disease (CAD) and 282 (5.7%) had peripheral artery disease (PAD)/gangrene. The median number of the various macrovascular admissions were CVA 67 (IQR 58-75), CAD 59 (IQR 55-71) and PVD 62 (IQR 52-72) (p<0.001 by Kruskal-Wallis). The male:female ratios were 2:1, 1 
Adrenal disorders
Adrenal disorders constituted 84 (1.5%) endocrine admissions, with a male:female ratio of 1 
Metabolic syndrome
Metabolic syndrome constituted 72 (1.3%) of all cases of endocrine disease admitted, with a mean age of 49.0±15.0 y. Hypertensive heart disease and arrhythmias were the most frequent accompaniments. The overall case fatality rate was 6.7%.
Disorders of calcium and bone metabolism
Disorders of calcium and bone metabolism represented 52 (1.0%) of the endocrine admissions over the period under study. The mean age of admission was 37.2±18.0 y with a male: female ratio of 1:1.4. Hypercalcaemia represented 81% (n=42) of the cases with a median of 33 (IQR 24-56) and hypocalcaemia (n=10) representing 48% with median age of admission of 32 y (IQR 20-33) and male:female ratio of 1:1. The causes of hypercalcaemia included chronic kidney disease and primary hyperparathyroidism. In the case of hypoparathyroidism, the most common causes were parathyroid and thyroid surgeries. The overall case fatality rate was 20%.
Miscellaneous disorders
Miscellaneous disorders constituted 34 (0.9%) of the endocrine disorders, with the mean age of 66.3±9.2 y and a male:female ratio of 2:1. The overall case fatality rate was 12.8%. Some of these disorders included thyroid abscesses (n=3), various disorders causing a syndrome of inappropriate antidiuretic hormone secretion (n=18), autoimmune polyglandular syndromes (n=8) and multiple endocrine neoplasias (n=5).
Duration of admission
The overall median duration of admission of patients with endocrine disorders was 5 d (IQR 3-8), with disorders of the pituitary gland requiring the longest duration of 8 d (IQR 2-9) and hyperthyroidism requiring 3 d (IQR [5] [6] [7] [8] . With almost all endocrine conditions, those who were discharged spent a relatively longer duration compared with those who died ( Table 4 ).
Predictors of mortality
Increasing age at admission was associated with an increased risk of death, with each 10-y increase in age associated with an adjusted hazard ratio (aHR) of 1.23 (95% confidence interval [CI] 1.12 to 1.53; p<0.001), as shown in Table 5 and illustrated in Fig. 1 . The probability of death was greatest with adrenal disorders, followed by metabolic syndrome, pituitary disorders, parathyroid and calcium homeostasis, diabetes and thyroid disorders, as depicted in Fig. 2 . Among people with diabetes, the probability of death was predicted by age (aHR 1.12 [95% CI 1.04 to 1.17]) for each 10-y increase in age. The probability of death was highest in those with type 2 diabetes (aHR 2.23 [95% CI 1.95 to 2.50], p<0.0001) and specific causes of diabetes (aHR 1.12 [95% CI 1.02 to 1.63], p<0.0002) compared with type 1 diabetes (Fig. 3) . Cardiovascular, neurological, infections, renal and glycaemic complications were associated with a significant International Health probability of death, as shown in Fig. 4 
Discussion
Endocrine disorders represented almost 10% of medical admissions to the KATH over the study period, with an average admission of 600 patients per year. Patients presented with a broad spectrum of endocrine disorders, with diabetes and thyroid disorders representing the two most frequent causes of endocrine admissions. In patients presenting with both diabetes and other endocrine disorders, cardiovascular complications predominated. This observation highlights the well-described growing menace of NCDs and uncontrolled vascular risk factors such as diabetes, hypertension, dyslipidaemia, obesity and physical inactivity that has emerged in populations of SSA over the past few decades. [15] [16] [17] [18] This has resulted from the adoption of westernised lifestyles leading to an epidemiological transition in SSA, of which Ghana has not been spared. 4, 5 An overall endocrine case fatality rate of 17% obtained in this population is significantly high compared with the mortality rates obtained in other areas of the world. 19, 20 O. Sarfo-Kantanka et al.
The poor outcomes of endocrine disorders in Ghana can be attributed to a combination of factors, including late presentation of patients, patients presenting with multiple and severe pathologies, fragmented institutional care of endocrine patients and a severe lack of endocrinologists in the country, as well as the lack of lifesaving emergency medications, insufficient equipment and infrastructure required for acute management of patients with endocrine emergencies. Deaths from hypoglycaemia, which seems to be almost unheard of in the developed world, was found to be relatively high in this study (16%). This is largely attributed to the low rate of education among diabetes patients, especially those on insulin and other hypoglycaemic agents. In addition, the high burden of diabetes complications, including nephropathy, shown in this study may serve as a contributing factor to the worse outcomes associated with hypoglycaemia. Other reasons include late presentation among patients and the absence of glucagon to provide immediate relief for these patients at the time of need.
A similar situation is seen in the high risk of death among patients with hypothyroidism. Most of these patients present late, with significant cardiac complications, thus exposing them to greater risk of death. Additionally, in the past, endocrine emergencies constituted only a small percentage of emergencies and the inpatient workload (<2%) seen by general doctors, with most of these patients presenting with diabetes-related complications. 21 This resulted in a situation where most general practitioners had insufficient exposure to other endocrine disorders and diabetes complications, causing them to be less confident in the management of these disorders. This resulted in increased mortality when confronted with such cases.
Endocrine disorders, like most other NCDs, are common in the elderly, causing a significant association with increased mortality. It should be noted that most elderly patients usually present with additional comorbidities, mostly cardiovascular disorders, thereby increasing their risk of death. The observed age distributions also lend credence to the hypothesis that adult populations in developing countries may have an increased susceptibility to diabetes and other endocrine illnesses due to the socio-economic deprivation that was present during their infancy and childhood, possibly leading to the earlier manifestations of these disorders. [21] [22] [23] Although a broad spectrum of endocrine-related illness was observed in this study, highlighting the epidemiology of diseases in middle-income countries where a transition from infections to NCDs has occurred, diabetes remains the leading cause of endocrine admission in consonance with various other diseases. [24] [25] [26] Recently a study in our hospital reported a 633% increase in admission rates over a 31-y period. Importantly, no significant improvements in mortality rates have been achieved over this 31-y period. 11 A significant proportion of diabetes admissions were complicated by CVDs. 27 This often reflects the severity of the underlying disease or delayed hospitalisation, although indicators of severity and the duration of symptoms before presentation were not assessed in this study.
Thyroid disorders represented the second most prevalent cause of endocrine admission in our study. More than 80% of patients presented with hyperfunction of the thyroid gland, in line with findings from other African countries and other areas of initial hypothyroidism, where the transition from iodine deficiency to iodine sufficiency achieved through iodisation of salt has resulted in an increasing prevalence of hyperthyroidism. [28] [29] [30] [31] [32] The relatively high number of patients with Graves' disease or toxic multinodular goitres seen in our study may have resulted from >20 y of unregulated iodination in Ghana. 33 The relatively low levels of endocrine disorders apart from diabetes and thyroid disorders can potentially be explained by patients being missed at the emergency room, as most of these disorders require a high index of suspicion and can easily be mistaken for other common diseases, especially in settings where there is no constant availability of radiological services and other critical investigative tools.
The main limitation of this study is its retrospective nature with the inherent absence of data completeness. Additionally, the study was not accompanied by biochemical and radiological results, which would have served as useful tools for comparison and confirmation of the various diagnosis. The main strengths of the study are its longitudinal design over a 9-y period and it being the first of its kind in the subregion to report on endocrine disorders.
The practice of endocrinology in resource-limited settings like Ghana is thus constrained by inadequate diagnostic support and a substantial disease burden. A clearer picture of the endocrine burden will continue to emerge in the coming years as more endocrinologists are trained and determinants of outcomes of endocrine disorders become clearer. Such data will be International Health
